| Customization: | Available |
|---|---|
| Powder: | Yes |
| Customized: | Customized |
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
PRL-8-53 is a nootropic research chemical derived from benzoic acid
and phenylmethylamine (Benzylamine) that has been shown to act as a hypermnesic drug in humans; it was first synthesized by medical chemistry professor Nikolaus Hansl atCreighton University in the 1970s as part of his work on amino ethyl meta benzoic acid esters.
PRL-8-53 is relatively non-toxic, with an oral LD50 in mice of 860 mg/kg,
giving the drug a high therapeutic index. Doses above 8 mg/kg have brief hypotensiveeffects in the canine.High doses depress motor activity in the rat and mouse, with the ED50 for a 50% reduction in motor activity of mice at 160 mg/kg.
| Name |
PRL-8-53
|
|
Synonyms:
|
PRL-8053;PRL-8-53;Methyl 3-(2-(benzyl(Methyl)aMino)ethyl)benzoate hydrochloride;3-(2-Benzyl(methyl)aminoethyl)benzoic acid methyl ester hydrochloride;m-[2-(Benzylmethylamino)ethyl]benzoic acid methyl ester hydrochloride;Benzoic acid, 3-(2-(Methyl(phenylMethyl)aMino)ethyl)-, Methyl ester, hydrochloride
|
|
CAS:
|
51352-87-5
|
|
MF:
|
C18H22ClNO2
|
|
MW:
|
319.82578
|
1. Prl-8-53 can Enhance cognition and memory formation
2. Prl-8-53 can Anxiolytic properties
3. Prl-8-53 can Anti-depressive effect
4. Prl-8-53 can Treatment of Alzheimer's and Parkinson's disease
5. Prl-8-53 can Increase coordination
6. Prl-8-53 can Improves mood
7. Prl-8-53 can Help fight fatigue
8. Prl-8-53 can Prevent oxidation within the brain
9. Prl-8-53 can Treat alcohol related brain damage
10. Prl-8-53 can Prevent caffe ine withdrawal symptoms
){kind=link}